Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$32.57 - $42.83 $28.7 Million - $37.8 Million
-882,138 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$23.3 - $45.96 $14.2 Million - $28 Million
-610,083 Reduced 40.88%
882,138 $30.7 Million
Q4 2019

Feb 14, 2020

BUY
$34.58 - $48.06 $6.86 Million - $9.54 Million
198,414 Added 15.34%
1,492,221 $64 Million
Q3 2019

Nov 14, 2019

SELL
$36.98 - $48.45 $8.06 Million - $10.6 Million
-217,978 Reduced 14.42%
1,293,807 $47.8 Million
Q2 2019

Aug 14, 2019

BUY
$35.13 - $55.53 $47.2 Million - $74.6 Million
1,343,403 Added 797.83%
1,511,785 $68.3 Million
Q1 2019

May 15, 2019

SELL
$42.83 - $59.91 $58.1 Million - $81.2 Million
-1,356,175 Reduced 88.96%
168,382 $9.15 Million
Q4 2018

Feb 14, 2019

SELL
$37.97 - $60.16 $18.7 Million - $29.6 Million
-492,693 Reduced 24.42%
1,524,557 $70.6 Million
Q2 2018

Aug 14, 2018

BUY
$44.9 - $64.95 $665,103 - $962,104
14,813 Added 0.74%
2,017,250 $126 Million
Q1 2018

May 15, 2018

SELL
$45.35 - $61.65 $2.05 Million - $2.79 Million
-45,300 Reduced 2.21%
2,002,437 $92.5 Million
Q4 2017

Feb 14, 2018

BUY
$41.95 - $60.1 $13.1 Million - $18.8 Million
312,060 Added 17.98%
2,047,737 $97.1 Million
Q3 2017

Nov 14, 2017

BUY
$33.4 - $53.9 $58 Million - $93.6 Million
1,735,677
1,735,677 $93.4 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.